Moolec Science SA Ordinary Shares
MLECMoolec Science SA is a biotechnology company focused on developing and commercializing plant-based proteins for the food and ingredient industries. It leverages scientific innovation to produce sustainable, allergen-free, and high-quality ingredients through molecular farming techniques using plants as biofactories. The company aims to revolutionize the production of proteins by offering alternative, eco-friendly solutions to traditional animal and microbial sources.
Company News
Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged 14.4% to $40.34 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Atreca, Inc. (NASDAQ: BCEL) shares surged 128.2%...
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.07% to 37,723.53 while the NASDAQ rose 0.46% to 15,039.09. The S&P 500 also rose, gaining, 0.21% to 4,793.32. Check This Out: Top 5 Materials Stocks That Are Ticking Portfolio Bombs  L...
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. Assembly Biosciences, Inc. (NASDAQ: ASMB) gained 120% to $1.5982 after the company and Gilead announced they entered into a 12-year partnership to advance the research and...
Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 reverse split on July 10. Wah Fu Education Group Limited (NASDAQ: WAFU) shares gained 35.2% to $3.07 in pre-market trading. Snail, Inc. (NASDAQ: SNAL) shares rose 29.7% to $2.14 in pre-market trading after gaining ...
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lu...
